Subclinical and Clinical Eating Disorders in IDDM Negatively Affect Metabolic Control

Abstract

HbA1c may have clinical utility in the identification of eating disorder behavior in females with IDDM. Health care professionals should be aware of the potent effect of subclinical and clinical eating behaviors including insulin misuse in weight-conscious women with IDDM who have poor glycemic control.